BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21302136)

  • 1. Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression.
    Wang YC; Xu GL; Jia WD; Han SJ; Ren WH; Wang W; Liu WB; Zhang CH; Chen H
    Inflammation; 2012 Feb; 35(1):143-9. PubMed ID: 21302136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of physiological doses of estrogen during hepatocarcinogenesis induced by diethylnitrosamine and N-nitrosomorpholine.
    Wang YC; Xu GL; Jia WD; Han SJ; Ren WH; Liu WB; Zhang CH; Wang W; Chen H
    Hepatogastroenterology; 2011; 58(112):2032-5. PubMed ID: 22234074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma.
    Futakuchi M; Ogawa K; Tamano S; Takahashi S; Shirai T
    Cancer Sci; 2004 Jan; 95(1):18-24. PubMed ID: 14720322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.
    Futakuchi M; Ogawa K; Sano M; Tamano S; Takeshita F; Shirai T
    Jpn J Cancer Res; 2002 Oct; 93(10):1175-81. PubMed ID: 12417048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Attenuates Diethylnitrosamine-Induced Hepatocellular Carcinoma in Female Rats via Modulation of Estrogen Receptor/FASN/CD36/IL-6 Axis.
    Abdel-Hamid MS; Mansour AM; Hassan MH; Abdelhady R; Elsadek BEM; El-Sayed EM; Salama SA
    Biol Pharm Bull; 2023; 46(11):1558-1568. PubMed ID: 37914358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine.
    Yoshino H; Futakuchi M; Cho YM; Ogawa K; Takeshita F; Imai N; Tamano S; Shirai T
    Clin Exp Metastasis; 2005; 22(5):441-7. PubMed ID: 16283487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
    Erös de Bethlenfalva-Hora C; Mertens JC; Piguet AC; Kettenbach J; Schmitt J; Terracciano L; Weimann R; Dufour JF; Geier A
    Clin Sci (Lond); 2014 Feb; 126(3):243-52. PubMed ID: 23822114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model.
    Futakuchi M; Hirose M; Ogiso T; Kato K; Sano M; Ogawa K; Shirai T
    Jpn J Cancer Res; 1999 Nov; 90(11):1196-202. PubMed ID: 10622528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
    Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
    Jiang T; Zhang X; Ding J; Duan B; Lu S
    Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor levels and occupancy in hepatic sinusoidal endothelial and Kupffer cells are enhanced by initiation with diethylnitrosamine and promotion with 17alpha-ethinylestradiol in rats.
    Vickers AE; Lucier GW
    Carcinogenesis; 1996 Jun; 17(6):1235-42. PubMed ID: 8681437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEDF effectively decreases VEGF to PEDF messenger RNA ratio of the inner edge of rat hepatocellular carcinoma induced by diethyl nitrosamine - an "in vivo" study.
    Jeng KS; Sheen IS; Jeng WJ; Su JC
    Hepatogastroenterology; 2012; 59(117):1484-90. PubMed ID: 22057317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.
    Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A
    Hepatology; 1996 Oct; 24(4):849-54. PubMed ID: 8855187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes.
    Masui T; Nakanishi H; Inada K; Imai T; Mizoguchi Y; Yada H; Futakuchi M; Shirai T; Tatematsu M
    Cancer Lett; 1997 Jan; 112(1):33-45. PubMed ID: 9029167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects.
    Krattenmacher R; Knauthe R; Parczyk K; Walker A; Hilgenfeldt U; Fritzemeier KH
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):207-14. PubMed ID: 8142296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma.
    Jang JW; Park ST; Kwon JH; You CR; Choi JY; Jung CK; Bae SH; Yoon SK
    Exp Mol Med; 2011 May; 43(5):305-12. PubMed ID: 21483229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity.
    Taras D; Blanc JF; Rullier A; Dugot-Senant N; Laurendeau I; Vidaud M; Rosenbaum J
    J Hepatol; 2007 Jan; 46(1):69-76. PubMed ID: 16935385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
    Song SS; Yuan PF; Li PP; Wu HX; Ni WJ; Lu JT; Wei W
    Immunol Invest; 2015; 44(6):521-35. PubMed ID: 26207789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in estrogen receptor, DNA ploidy, and estrogen metabolism in rat hepatocytes during a two-stage model for hepatocarcinogenesis using 17 alpha-ethinylestradiol as the promoting agent.
    Vickers AE; Nelson K; McCoy Z; Lucier GW
    Cancer Res; 1989 Dec; 49(23):6512-20. PubMed ID: 2573415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estrogens as promoters of hepatic neoplasia.
    Wanless IR; Medline A
    Lab Invest; 1982 Mar; 46(3):313-20. PubMed ID: 6278220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.